Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.68 |
| ▸ | SHBG | P04278 | 1/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.56 |
| ▸ | PGR | P06401 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17302789 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL13177160 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL13804528 | 1.00 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL3458086 | 0.91 | MAPT (0.71) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL24103254 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL9473555 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL6445859 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL24103304 | 0.90 | MAPT (0.69) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL21067996 | 0.89 | MAPT (0.84) | MAPTLMNASERPINA6ALDH1A1SLC22A1 | |
| SCHEMBL343128 | 0.88 | MAPT (0.79) | MAPTLMNASERPINA6ALDH1A1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-107353318-A | The preparation method of 6 dehydrogenation nandrolone acetates | 湖北共同生物科技有限公司 | 2017-11-17 | — | — | CN | claimed |
| CN-107188916-A | A kind of preparation method of 6 dehydrogenation nandrolone acetate | 湖北工业大学 | 2017-09-22 | — | — | CN | claimed |
| US-20250281509-A1 | SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER | THE JOHNS HOPKINS UNIVERSTY | 2025-09-11 | — | — | US | disclosed |
| US-11912737-B2 | 19-nor neuroactive steroids and methods of use thereof | Sage Therpeutics, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912737-B2 | 19-nor neuroactive steroids and methods of use thereof | Sage Therpeutics, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| EP-4144746-A1 | NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | Sage Therapeutics, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | disclosed |
| US-11241446-B2 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | SAGE THERAPEUTICS, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-4048195-A | Process of synthesizing substituted indanones | HOFFMANN-LA ROCHE INC. (US) | 1977-09-13 | — | — | US | disclosed |
| US-4044004-A | Total steroid synthesis employing substituted isoxazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 1977-08-23 | — | — | US | disclosed |
| US-4004005-A | NON-PYROGENIC | AKZONA INCORPORATED (US) | 1977-01-18 | — | — | US | disclosed |
| US-3985733-A | Stereospecific total steroidal synthesis via substituted C/D-trans indanones | HOFFMANN-LA ROCHE INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3985771-A | Total steroid synthesis employing substituted isoxazole derivatives | HOFFMANN-LA ROCHE INC. (US) | 1976-10-12 | — | — | US | disclosed |
| US-3984473-A | Stereospecific total steroidal synthesis via substituted C/D-trans indanones | HOFFMANN-LA ROCHE INC. (US) | 1976-10-05 | — | — | US | disclosed |
| US-3984428-A | Isoxazolyl-substituted perhydrobenzindenes | HOFFMANN-LA ROCHE INC. (US) | 1976-10-05 | — | — | US | disclosed |
| US-3965117-A | Stereospecific total steroidal synthesis via substituted c/d-trans indanones | HOFFMANN-LA ROCHE INC. (US) | 1976-06-22 | — | — | US | disclosed |
| US-3950389-A | Stereospecific total steroidal synthesis via substituted C/D-trans indanones | HOFFMANN-LA ROCHE INC. (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912737-B2 | 19-nor neuroactive steroids and methods of use thereof | NR3C2, HSD3B1, HSD3B2 | MAPT 1029/4885LMNA 2913/4885SERPINA6 407/4885 |
| US-11241446-B2 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | NR3C2, NR3C1, CYP11B1 | MAPT 1772/4885LMNA 2657/4885SERPINA6 1023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.